7 results on '"Bischoff S. C."'
Search Results
2. Glutamine-enriched total parenteral nutrition in patients with inflammatory bowel disease
- Author
-
Ockenga, J, Borchert, K, Stüber, E, Lochs, H, Manns, M P, and Bischoff, S C
- Published
- 2005
- Full Text
- View/download PDF
3. Gastroenterology – Guidelines on Parenteral Nutrition, Chapter 15
- Author
-
Schulz, R. J., Working group for developing the guidelines for parenteral nutrition of The German Association for Nutritional Medicine, Koletzko, B., and Bischoff, S. C.
- Subjects
inflammatory bowel disease ,Crohn's disease ,ulcerative colitis ,pancreatitis ,Medicine - Abstract
In patients with Crohn's disease and ulcerative colitis parenteral nutrition (PN) is indicated when enteral nutrition is not possible or should be avoided for medical reasons. In Crohn's patients PN is indicated when there are signs/symptoms of ileus or subileus in the small intestine, scars or intestinal fistulae. PN requires no specific compounding for chronic inflammatory bowel diseases. In both diseases it should be composed of 55–60% carbohydrates, 25–30% lipids and 10–15% amino acids. PN helps in the correction of malnutrition, particularly the intake of energy, minerals, trace elements, deficiency of calcium, vitamin D, folic acid, vitamin B12, and zinc. Enteral nutrition is clearly superior to PN in severe, acute pancreatitis. An intolerance to enteral nutrition results in an indication for total PN in complications such as pseudocysts, intestinal and pancreatic fistulae, and pancreatic abscesses or pancreatic ascites. If enteral nutrition is not possible, PN is recommended, at the earliest, 5 days after admission to the hospital. TPN should not be routinely administered in mild acute pancreatitis or nil by moth status
- Published
- 2009
4. Quantification of Inflammatory Mediators in Stool Samples of Patients with Inflammatory Bowel Disorders and Controls
- Author
-
Bischoff, S. C., Grabowsky, J., and Manns, M. P.
- Published
- 1997
- Full Text
- View/download PDF
5. Practical guideline on obesity care in patients with gastrointestinal and liver diseases - Joint ESPEN/UEG guideline
- Author
-
Stephan C. Bischoff, Johann Ockenga, Ahad Eshraghian, Rocco Barazzoni, Luca Busetto, Marjo Campmans-Kuijpers, Vincenzo Cardinale, Irit Chermesh, Haluk Tarik Kani, Wafaa Khannoussi, Laurence Lacaze, Miguel Léon-Sanz, Juan M. Mendive, Michael W. Müller, Frank Tacke, Anders Thorell, Darija Vranesic Bender, Arved Weimann, Cristina Cuerda, and Bischoff S. C., Ockenga J., Eshraghian A., Barazzoni R., Busetto L., Campmans-Kuijpers M., Cardinale V., Chermesh I., KANİ H. T., Khannoussi W., et al.
- Subjects
Internal Diseases ,Tarımsal Bilimler ,Yoğun Bakım Tıbbı ,NUTRITION & DIETETICS ,Beslenme ve Diyetetik ,Yoğun Bakım ,Sağlık Bilimleri ,Critical Care and Intensive Care Medicine ,Gastroesophageal reflux disease ,İç Hastalıkları ,Clinical Medicine (MED) ,Inflammatory bowel disease ,BESLENME VE DİYETETİK ,Ziraat ,Health Sciences ,Tarım Bilimleri ,Beslenme ve Dietetik ,Klinik Tıp (MED) ,Tarım ve Çevre Bilimleri (AGE) ,Obesity ,Irritable bowel syndrome, celiac disease ,Internal Medicine Sciences ,Nutrition and Dietetics ,Sarcopenic obesity ,Klinik Tıp ,Agricultural Sciences ,Intensive Care ,Agriculture ,Dahili Tıp Bilimleri ,Agriculture & Environment Sciences (AGE) ,CLINICAL MEDICINE ,Tıp ,Irritable bowel syndrome ,Pancreatitis ,YOĞUN BAKIM ,Medicine ,CRITICAL CARE MEDICINE ,celiac disease - Abstract
BACKGROUND: Patients with chronic gastrointestinal disease such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux disease (GERD), pancreatitis, and chronic liver disease (CLD) often suffer from obesity because of coincidence (IBD, IBS, celiac disease) or related pathophysiology (GERD, pancreatitis and CLD). It is unclear if such patients need a particular diagnostic and treatment that differs from the needs of lean gastrointestinal patients. The present guideline addresses this question according to current knowledge and evidence.OBJECTIVE: The present practical guideline is intended for clinicians and practitioners in general medicine, gastroenterology, surgery and other obesity management, including dietitians and focuses on obesity care in patients with chronic gastrointestinal diseases.METHODS: The present practical guideline is the shortened version of a previously published scientific guideline developed according to the standard operating procedure for ESPEN guidelines. The content has been re-structured and transformed into flow-charts that allow a quick navigation through the text.RESULTS: In 100 recommendations (3× A, 33× B, 24 × 0, 40× GPP, all with a consensus grade of 90% or more) care of gastrointestinal patients with obesity - including sarcopenic obesity - is addressed in a multidisciplinary way. A particular emphasis is on CLD, especially metabolic associated liver disease, since such diseases are closely related to obesity, whereas liver cirrhosis is rather associated with sarcopenic obesity. A special chapter is dedicated to obesity care in patients undergoing bariatric surgery. The guideline focuses on adults, not on children, for whom data are scarce. Whether some of the recommendations apply to children must be left to the judgment of the experienced pediatrician.CONCLUSION: The present practical guideline offers in a condensed way evidence-based advice how to care for patients with chronic gastrointestinal diseases and concomitant obesity, an increasingly frequent constellation in clinical practice.
- Published
- 2023
6. European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint ESPEN/UEG guideline
- Author
-
Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, Marjo Campmans-Kuijpers, Vincenzo Cardinale, Irit Chermesh, Ahad Eshraghian, Haluk Tarik Kani, Wafaa Khannoussi, Laurence Lacaze, Miguel Léon-Sanz, Juan M. Mendive, Michael W. Müller, Johann Ockenga, Frank Tacke, Anders Thorell, Darija Vranesic Bender, Arved Weimann, Cristina Cuerda, and Bischoff S. C. , Barazzoni R., Busetto L., Campmans-Kuijpers M., Cardinale V., Chermesh I., Eshraghian A., KANİ H. T. , Khannoussi W., Lacaze L., et al.
- Subjects
Adult ,Sarcopenia ,Tarımsal Bilimler ,NUTRITION & DIETETICS ,Beslenme ve Diyetetik ,Y GASTRIC BYPASS ,CONTROLLED ATTENUATION PARAMETER ,GASTROESOPHAGEAL-REFLUX DISEASE ,EXOCRINE PANCREATIC INSUFFICIENCY ,Critical Care and Intensive Care Medicine ,Sağlık Bilimleri ,Inflammatory bowel disease ,Irritable Bowel Syndrome ,BESLENME VE DİYETETİK ,Ziraat ,Health Sciences ,Tarım Bilimleri ,Humans ,Beslenme ve Dietetik ,NONALCOHOLIC FATTY LIVER ,Tarım ve Çevre Bilimleri (AGE) ,Obesity ,Child ,Bariatric surgery ,Nutrition and Dietetics ,Sarcopenic obesity ,Agricultural Sciences ,Liver Diseases ,Non-alcoholic fatty liver disease ,Agriculture ,Agriculture & Environment Sciences (AGE) ,Inflammatory Bowel Diseases ,POST-BARIATRIC SURGERY ,BODY-MASS INDEX ,Celiac Disease ,Pancreatitis ,LIFE-STYLE INTERVENTION ,Gastroesophageal Reflux ,CLINICAL-PRACTICE GUIDELINES ,INFLAMMATORY-BOWEL-DISEASE - Abstract
Background: Patients with chronic gastrointestinal (GI) disease such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux disease (GERD), pancrea-titis, and chronic liver disease (CLD) often suffer from obesity because of coincidence (IBD, IBS, celiac disease) or related pathophysiology (GERD, pancreatitis and CLD). It is unclear if such patients need a particular diagnostic and treatment that differs from the needs of lean GI patients. The present guideline addresses this question according to current knowledge and evidence.Objective: The objective of the guideline is to give advice to all professionals working in the field of gastroenterology care including physicians, surgeons, dietitians and others how to handle patients with GI disease and obesity.Methods: The present guideline was developed according to the standard operating procedure for ESPEN guidelines, following the Scottish Intercollegiate Guidelines Network (SIGN) grading system (A, B, 0, and good practice point (GPP)). The procedure included an online voting (Delphi) and a final consensus conference.Results: In 100 recommendations (3x A, 33x B, 24x 0, 40x GPP, all with a consensus grade of 90% or more) care of GI patients with obesity -including sarcopenic obesity -is addressed in a multidisciplinary way. A particular emphasis is on CLD, especially fatty liver disease, since such diseases are closely related to obesity, whereas liver cirrhosis is rather associated with sarcopenic obesity. A special chapter is dedi-cated to obesity care in patients undergoing bariatric surgery. The guideline focuses on adults, not on children, for whom data are scarce. Whether some of the recommendations apply to children must be left to the judgment of the experienced pediatrician.Conclusion: The present guideline offers for the first time evidence-based advice how to care for patients with chronic GI diseases and concomitant obesity, an increasingly frequent constellation in clinical practice.(c) 2022 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
- Published
- 2022
7. European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline
- Author
-
Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, Marjo Campmans‐Kuijpers, Vincenzo Cardinale, Irit Chermesh, Ahad Eshraghian, Haluk Tarik Kani, Wafaa Khannoussi, Laurence Lacaze, Miguel Léon‐Sanz, Juan M. Mendive, Michael W. Müller, Johann Ockenga, Frank Tacke, Anders Thorell, Darija Vranesic Bender, Arved Weimann, Cristina Cuerda, and Bischoff S. C. , Barazzoni R., Busetto L., Campmans-Kuijpers M., Cardinale V., Chermesh I., Eshraghian A., KANİ H. T. , Khannoussi W., Lacaze L., et al.
- Subjects
Internal Diseases ,Sarcopenia ,obesity ,gastroesophageal reflux disease ,pancreatitis ,Y GASTRIC BYPASS ,GASTROESOPHAGEAL-REFLUX DISEASE ,EXOCRINE PANCREATIC INSUFFICIENCY ,Sağlık Bilimleri ,İç Hastalıkları ,Clinical Medicine (MED) ,sarcopenic obesity ,celiacdisease ,Klinik Tıp (MED) ,NONALCOHOLIC FATTY LIVER ,Child ,Klinik Tıp ,gastroesophagealrefluxdisease ,Liver Diseases ,Gastroenterology ,GASTROENTEROLOJİ VE HEPATOLOJİ ,Tıp ,Hepatoloji ,Oncology ,LIFE-STYLE INTERVENTION ,Gastroesophageal Reflux ,Medicine ,Adult ,bariatric surgery ,CONTROLLED ATTENUATION PARAMETER ,Gastroenterology and Hepatology ,celiac disease ,cirrhosis ,inflammatory bowel disease ,irritable bowel syndrome ,non-alcoholic fatty liver disease ,Gastroenteroloji-(Hepatoloji) ,non‐alcoholicfattyliverdisease ,Health Sciences ,Humans ,inflammatoryboweldisease ,GLUTEN-FREE DIET ,Internal Medicine Sciences ,Hepatology ,GASTROENTEROLOGY & HEPATOLOGY ,irritablebowelsyndrome ,sarcopenicobesity ,Dahili Tıp Bilimleri ,CLINICAL MEDICINE ,Inflammatory Bowel Diseases ,POST-BARIATRIC SURGERY ,Gastroenteroloji ,BODY-MASS INDEX ,bariatricsurgery ,INFLAMMATORY-BOWEL-DISEASE - Abstract
Background Patients with chronic gastrointestinal (GI) disease such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux disease (GERD), pancreatitis, and chronic liver disease (CLD) often suffer from obesity because of coincidence (IBD, IBS, celiac disease) or related pathophysiology (GERD, pancreatitis and CLD). It is unclear if such patients need a particular diagnostic and treatment that differs from the needs of lean GI patients. The present guideline addresses this question according to current knowledge and evidence. Objective The objective of the guideline is to give advice to all professionals working in the field of gastroenterology care including physicians, surgeons, dietitians and others how to handle patients with GI disease and obesity. Methods The present guideline was developed according to the standard operating procedure for European Society for Clinical Nutrition and Metabolism guidelines, following the Scottish Intercollegiate Guidelines Network grading system (A, B, 0, and good practice point [GPP]). The procedure included an online voting (Delphi) and a final consensus conference. Results In 100 recommendations (3x A, 33x B, 24x 0, 40x GPP, all with a consensus grade of 90% or more) care of GI patients with obesity - including sarcopenic obesity - is addressed in a multidisciplinary way. A particular emphasis is on CLD, especially fatty liver disease, since such diseases are closely related to obesity, whereas liver cirrhosis is rather associated with sarcopenic obesity. A special chapter is dedicated to obesity care in patients undergoing bariatric surgery. The guideline focuses on adults, not on children, for whom data are scarce. Whether some of the recommendations apply to children must be left to the judgment of the experienced pediatrician. Conclusion The present guideline offers for the first time evidence-based advice how to care for patients with chronic GI diseases and concomitant obesity, an increasingly frequent constellation in clinical practice.
- Published
- 2022
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.